Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Non Operating Income (2020 - 2025)

LifeStance Health (LFST) has disclosed Non Operating Income for 6 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 123.64% to $6.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $123000.0, a 100.56% increase, with the full-year FY2025 number at $123000.0, up 100.47% from a year prior.
  • Non Operating Income was $6.2 million for Q4 2025 at LifeStance Health, up from $24000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $11.5 million in Q4 2023 to a low of -$26.8 million in Q2 2021.
  • A 5-year average of -$4.6 million and a median of -$3.0 million in 2025 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: tumbled 121809.09% in 2021, then skyrocketed 396.76% in 2024.
  • LifeStance Health's Non Operating Income stood at -$20.1 million in 2021, then dropped by 12.88% to -$22.7 million in 2022, then surged by 150.73% to $11.5 million in 2023, then plummeted by 326.47% to -$26.1 million in 2024, then soared by 123.64% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Non Operating Income are $6.2 million (Q4 2025), $24000.0 (Q3 2025), and -$3.0 million (Q2 2025).